HIV Testing in Women: Missed Opportunities by Duffus, Wayne A. et al.
University of South Carolina
Scholar Commons
Faculty Publications Health Services Policy and Management
2-2012




University of South Carolina - Columbia, mdbyrd01@mailbox.sc.edu
Khosrow Heidari
Terri G. Stephens
See next page for additional authors
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_health_services_policy_management_facpub
Part of the Public Health Commons
This Article is brought to you by the Health Services Policy and Management at Scholar Commons. It has been accepted for inclusion in Faculty
Publications by an authorized administrator of Scholar Commons. For more information, please contact dillarda@mailbox.sc.edu.
Publication Info
Published in Journal of Women's Health, Volume 21, Issue 2, 2012, pages 170-178.
Duffus, W. A., Davis, H. T., Byrd, M. D., Heidari, K., Stephens, T. G., & Gibson, J. J. (2012). HIV testing in women: Missed
opportunities. Journal of Women's Health, 21(2), 170-178.
DOI: 10.1089/jwh.2010.2655
© Journal of Women's Health, 2012, Mary Ann Liebert, Inc.
Author(s)
Wayne A. Duffus, Harley T. Davis, Michael D. Byrd, Khosrow Heidari, Terri G. Stephens, and James J. Gibson
This article is available at Scholar Commons: https://scholarcommons.sc.edu/sph_health_services_policy_management_facpub/4
HIV Testing in Women: Missed Opportunities
Wayne A. Duffus, M.D., Ph.D.,1,2 Harley T. Davis, M.S.P.H.,3 Michael D. Byrd, Ph.D.,4
Khosrow Heidari, M.S.,5 Terri G. Stephens, M.S.P.H.,1 and James J. Gibson, M.D., M.P.H.1
Abstract
Objective: To investigate opportunities for early human immunodeficiency virus (HIV) testing of women.
Methods: A retrospective cohort study design linked case reports from HIV surveillance to several statewide
health-care databases. Medical encounters occurring before the first positive HIV test (missed opportunities)
were categorized by diagnosis/procedure codes to distinguish visits that were likely to have prompted an HIV
test. Women were categorized as late testers (AIDS diagnosis < 12 months from first HIV test date), non–late
testers (no AIDS diagnosis during study period or diagnosis of AIDS > 12 months of HIV diagnosis), of re-
productive age (13–44 years old), and not of reproductive age ( > 44 years old). Adjusted odds ratios (aOR) and
95% confidence intervals (CI) were used to estimate risk and its statistical significance.
Results: Of 3303 HIV-infected women diagnosed during the study period, 2408 (73%) had missed opportunity
visits. Late testers (39%) were more likely to be black than white (aOR 1.48, 95% CI 1.12–1.95), be older ( > 44
years old; aOR 7.85, 95% CI 4.49–13.7), and have > 10 missed opportunity visits (aOR 2.17, 95% CI 1.62–2.91).
Fifty-four percent of women > 44 years old were also late testers. Women > 44 years old had lower median initial
CD4 counts ( p < 0.001). The top two procedures were the same for all groups of women but mammography was
ranked fourth for women > 44 years old and Papanicolau smear was ranked fourth for late testers.
Conclusions: Feasibility and acceptability of routine HIV testing in nontraditional health-care settings, such as
mammography and Papanicolau screenings, should be explored to identify late testers and older (not of re-
productive age) HIV-infected women.
Introduction
Aprevious report demonstrated that human immu-nodeficiency virus (HIV) testing practices in South Car-
olina have failed to diagnose HIV infection in many cases
despite documented prior encounters with the medical sys-
tem (missed opportunities).1 It was found that 73.4% of in-
dividuals testing HIV positive had visited a South Carolina
health-care facility prior to the date of their first positive HIV
test and 43.4% of those testing HIV-positive developed AIDS
within 1 year of first testing. However, it remains to be
demonstrated if HIV-infected women have visited health-care
venues often viewed as nontraditional HIV testing sites prior
to their diagnosis. Implementation of HIV testing in both
traditional and nontraditional venues would offer the most
complete coverage of diagnostic services and allow for reali-
zation of the goals of the Centers for Disease Control and
Prevention (CDC) revised recommendations for HIV testing
in health-care settings.2
Disease stage at diagnosis is important because early diagnosis
(HIV-only) and prompt linkage to care allows for access to anti-
retroviral medications that may decrease transmission and im-
prove morbidity and mortality when compared with a late
diagnosis (AIDS).3 Women in South Carolina were more likely
than men to be diagnosed as HIV-only.1 The widespread im-
plementation of routine screening during prenatal years may
explain why women are diagnosed earlier than men. However,
this implies that there may be a gap in routine screening if a
woman is not having children and hence not accessing obstetri-
cal services. Also, it has not yet been proven if late HIV diagnosis
of women not of reproductive age results from either delayed
presentation for care or missed opportunities for early testing.
1Bureau of Disease Control, South Carolina Department of Health and Environmental Control, Columbia, South Carolina.
2Division of Infectious Diseases, Department of Internal Medicine, University of South Carolina School Of Medicine, Columbia, South
Carolina.
3Department of Environmental Health Sciences, 4Department of Health Services Policy and Management, University of South Carolina
Arnold School of Public Health, Columbia, South Carolina.
5Bureau of Chronic Diseases, South Carolina Department of Health and Environmental Control, Columbia, South Carolina.
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Further investigation of the association of gender, age, and
race with HIV testing is important because epidemiologic
data from the South Carolina Department of Health and En-
vironmental Control (SCDHEC) HIV/AIDS Reporting Sys-
tem (eHARS) show that many older African American
women were diagnosed late.4 This finding suggests that
providers and women, especially black women, may not
perceive themselves to be at risk for HIV infection but may be
at risk through their partners’ practices.5,6
Missed opportunities among older adults were associated
with a late diagnosis.7 This suggests dangerously prolonged
periods of unidentified infection in older adults who also
may not be perceived by themselves or health-care workers
to be at risk for HIV infection because of their age.8 In 2005,
the CDC estimated that individuals ‡ 50 years old accounted
for 15% of new HIV/AIDS diagnoses and 24% of persons
living with HIV/AIDS. Of HIV-infected persons who have
died, a reported 35% were more than 50 year old.9 Demo-
graphically, the rates of HIV/AIDS among persons 50 years
and older were 12 times higher among blacks (51.7/100,000)
and five times higher among Hispanics (21.4/100,000)
compared with whites (4.2/100,000). These rates are trou-
bling and suggest an emerging public health epidemic
among a vulnerable population.
To explore the possibility of additional opportunities for
earlier HIV diagnosis in women of and not of reproductive
age and women who tested early and those who tested late, a
population-based retrospective cohort study was devised that
linked HIV case surveillance data to several health-care da-
tabases: the centralized health department patient encounter
database, a federally subsidized breast and cervical cancer
screening program medical encounter database, and the
statewide hospital health-care database. Linkage of these four
databases allowed the investigators to (1) to assess if HIV
screening at nontraditional venues outside of obstetrical care
or an emergency department could identify HIV-infected
older women, and (2) determine whether specific diagnostic/
procedure codes at earlier health-care visits were associated
with a subsequent positive HIV test.
Methods
The SCDHEC and the Office of Research and Statistics
(ORS) of the State Budget and Control Board provided the
data used in this analysis. Both the SCDHEC Institutional
Review Board and ORS Data Oversight Committee approved
this study.
SCDHEC data
SCDHEC provided data sets from three sources: the HIV/
AIDS Reporting System (eHARS), Best Chance Network
(BCN),10 and the health department clinics’ Patient Auto-
mated Tracking System (PATS) database.
SCDHEC has had a confidential name-based reporting
system for HIV since 1986 and this information is maintained
in eHARS. The data quality of eHARS is high for both time-
liness of reporting (93% of cases reported within 6 months)
and completeness of reporting (97% of cases reported based
on a comparison with other data sources).11 State law requires
all licensed laboratories to report all CD4 + T-cell counts and
HIV viral load measurements to SCDHEC, and these data are
recorded in eHARS.
The study cohort of HIV-infected women was extracted
from eHARS and linked to the other data sets described in
following text, to explore for potential missed opportunity
health-care visits. Variables requested from eHARS include
date of first positive HIV test, date of AIDS diagnosis (if
applicable), route of transmission (heterosexual, intravenous
drug use, no identified risk, no risk reported), source of pos-
itive HIV test report (county health department, hospital,
private/group practice, other including Department of Cor-
rections and Mental Health), race/ethnicity (non-Hispanic
white, non-Hispanic black), and age at initial HIV diagnosis.
eHARS data were limited to women diagnosed with HIV
infection from January 1, 1996, to December 31, 2007, who
were South Carolina residents and at least 13 years of age at
HIV diagnosis. Women were followed until December 31,
2008, for determination of disease stage at diagnosis.
The BCN10 is a federal program that provides free breast
and cervical cancer screenings for medically underserved
women in South Carolina who have limited or no health in-
surance, are age 40–64 years old, and meet certain income
guidelines ( < 200% federal poverty level). The goal of the BCN
program is to reduce mortality from breast and cervical can-
cers among medically underserved women in South Carolina.
Funding has been provided by the CDC since 1991. Variables
requested from the BCN data set include dates of service and
results of procedures performed (Papanicolau smears and
mammograms).
PATS data are collected by SCDHEC staff during medical
encounters in the 46 county health department clinics, includ-
ing sexually transmitted disease (STD)/family planning, im-
munization, and tuberculosis (TB) clinics. Variables requested
from the PATS data set include date of visit, reason for visit,
diagnosis (both clinical and laboratory-based), and treatment
provided. Both positive and negative test results for syphilis,
gonorrhea, and chlamydia reported from the SCDHEC state
laboratory are also included with the PATS data set.
ORS data
ORS receives uniform billing data on medical encounters
that have occurred at 101 hospitals (inpatient, outpatient, im-
aging, and emergency departments), 77 ambulatory surgery
centers, and 22 free clinics in South Carolina (ORS, unpub-
lished data). Variables requested from the hospital discharge
(HD) data set include admission dates, payer of services
(commercial insurance, Medicaid, Medicare, indigent/self-
pay), International Statistical Classification of Diseases and Related
Health Problems (ICD-9) diagnostic and procedure codes, and
facility type.
Data linkage
The eHARS data set was linked to other health-care data
sets (PATS, BCN, HD) to determine visits that occurred before
the first positive HIV test date. The linkage variables included
patient name, birth date, gender, race/ethnicity, social secu-
rity number, and county of residence. Linkage took place in a
secure location and was completed by individuals trained in
ORS confidentiality procedures as well as the Health In-
surance Portability and Accountability Act. All protected
personal identifiers (name, social security number, address)
were removed by ORS staff before data were returned to
study investigators.
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Categorizations of women and visits
Women were categorized by both disease stage at diag-
nosis (late testers, AIDS diagnosis £ 12 months after the first
positive HIV test date; non–late testers, no diagnosis with
AIDS during the study period or diagnosed with AIDS > 12
months from first positive HIV test date) and reproductive
age (13–44 years old, of reproductive age; > 44 years old, not
of reproductive age). Women for which disease stage or age
could not be determined were excluded from the analysis.
The missed opportunity period was delineated using initial
median CD4 + T-cell counts obtained at diagnosis and calcu-
lating the length of time to reach that value from a normal
count following HIV infection.12 Accordingly, visits were
categorized as missed opportunities if they occurred within
3 years of the first positive HIV test for non–late testers and
within 10 years of first positive HIV test for late testers. Visits
not within the study period, duplicate visits, or those without
an associated date in each data set were excluded from the
analysis. Also, any visits related to HIV prevention and
treatment (HIV testing, counseling, partner notification) were
also deleted because these visits would not be classified as
missed opportunities.
Missed opportunity visits were further categorized by the
diagnosis and procedure codes assigned at the medical
encounter and reported to the BCN, PATS, or HD data sets.
The diagnostic codes were categorized either as those likely
to prompt an HIV test (AIDS-defining illnesses [e.g., toxo-
plasmosis, thrush], sexually transmitted infections, lymph-
adenopathy, pregnancy, gynecologically related diagnoses
[e.g., abnormal Papanicolau smear, cervical cancer], drug or
alcohol dependence) or as those not likely to prompt an HIV
test (e.g., hypertension, diabetes). Diagnoses likely to prompt
an HIV test were further investigated by categorizing into six
groups: (1) sexually transmitted infections, (2) AIDS-defining
illnesses and other symptoms, (3) abnormal Pap smear and
cervical cancer, (4) pregnancy and childbirth, (5) drug or al-
cohol dependence, and (6) hepatitis. The top 10 procedural
codes reported at medical encounters were determined for
all women, late testers, non–late testers, and women 13–44
years old and women > 44 years old. More than one proce-
dure or diagnosis code could be attributed to the same visit
and were counted separately.
Statistical analysis
The number of visits and the number of women with
missed opportunity visits were assessed for each data set
separately and the overall combined data sets. Chi-square test
for categorical variables and Kruskal–Wallis test for contin-
uous variables were used to measure the univariate differ-
ence among the groups. A multiple logistic regression model
was created to evaluate the differences among late testers
as compared with non–late testers, after controlling for race/
ethnicity, transmission category, source of HIV report, and
age group at the time of HIV diagnosis. Another multiple
logistic regression model was created to assess the differences
between women not of reproductive age ( > 44 years old) at
the time of diagnosis compared with women of reproductive
age (13–44 years old), after controlling for race/ethnicity,
transmission category, source of HIV report, and disease stage
at the time of diagnosis (AIDS/HIV-only). Measure of asso-
ciation is reported in terms of adjusted odds ratio (aOR)
and 95% confidence interval (CI). Furthermore, frequencies
were determined for diagnoses categorized as likely and not
likely to prompt an HIV test, as well as for missed opportunity
visits at which these diagnoses were coded. The diagnostic
codes assigned at missed opportunity visits were assessed
by univariate logistic regression analysis. In this case, missed
opportunity visits associated with illnesses/symptoms not
likely to prompt HIV testing (e.g., diabetes, hypertension)
were used as reference category. All statistical analyses were
performed with SAS version 9.1 (SAS Institute Inc.) using
two-sided tests and a < 0.05 for statistical significance.
Results
Of the 3303 women diagnosed with HIV from January 1,
1996, to December 31, 2007, and reported to eHARS, 2408
(73%) had missed opportunity visits for early testing at the
health-care settings examined in this study (Fig. 1). The me-
dian age at HIV diagnosis for the women was 35 years old.
Thirty-nine percent of women were identified as late testers
and, of these late testers, 79% were diagnosed with AIDS
within 1 month of their HIV diagnosis. The majority of wo-
men (76%) were 13–44 years old, while 54% of women who
were > 44 years old were also late testers.
There were 16,983 missed opportunity visits identified
in the combined data sets and most of these visits were to
hospital settings (*15,000 visits; range, 1–185; median, 4)
with the majority (74%) of hospital visits to emergency de-
partments (Fig. 1). Of all missed opportunity visits for HIV
diagnosis, 51% occurred among late testers, 27% among
women > 44 years old, and 19% among late-testing women
who were > 44 years old. For missed opportunity hospital
visits, the most common payer of services were Medicaid
(38%) and self-pay/indigent (35%). Medicaid was 35% of the
payer source for late testers and 29% of the payer source for
women > 44 years old.
Missed opportunities for early HIV testing represented 21%
(16,983/81,993) of all visits to health-care settings by women in
the combined data sets and, separately, 27% of the BCN visits,
21% of HD visits, and 20% of the PATS visits. Women had the
least number of missed opportunity visits to the BCN (range, 1–
7; median, 1). Approximately 21% of all missed opportunity
visits occurred within 6 months of HIV diagnosis.
The differences among women by disease stage at diagnosis
and by reproductive age are shown in Table 1. Late-testing
women were more likely than non–late testers to be black than
white (aOR 1.48, 95% CI 1.12–1.95), have more than 10 missed
opportunity visits (aOR 2.17, 95% CI 1.62–2.91), be diagnosed
with HIV infection in hospitals (aOR 2.62, 95% CI 2.08–3.29),
and be older. There was a significant increasing linear trend of
age for late-testing versus non–late-testing women ( p < 0.001
for trend). Median first CD4 counts were 101 cells/mm3 for late
testers and 464 cells/mm3 for non–late testers ( p < 0.001).
Women > 44 years old were more likely than women 13–44
years old to have no identified risk behavior (aOR 1.48, 95% CI
1.14–1.91) or to have no risk factor reported (aOR 1.71, 95% CI
1.29–2.28) as their HIV transmission category, be diagnosed
with HIV infection in hospitals (aOR 1.68, 95% CI 1.30–2.17),
and be late testers (aOR 2.21, 95% CI 1.80–2.70; Table 1).
Median first CD4 counts were 288 cells/mm3 for women
13–44 years old and 197 cells/mm3 for women > 44 years old
( p < 0.001).
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Of the 16,983 missed opportunity visits, 19% overall were
likely to prompt an HIV test; specifically, 11% for late testers
and 4% for women > 44 years old. All PATS visits were likely to
prompt an HIV test, with the majority of BCN (55%) and only
7% of HD visits likely to prompt an HIV test. The diagnostic
codes assigned at missed opportunity visits were associated
with significant odds of receiving a late diagnosis (Table 2).
The top two procedures by frequency (brief interview/
evaluation and injection/infusion of prophylaxis) were the
same for all women in the study cohort (Table 3). However,
Papanicolau smears were ranked number 4 for late testing
women and not in the top 10 procedure for non–late-testing
women. Manually assisted delivery was ranked number 4
for women 13–44 years old, while mammograms were
ranked number 4 for women > 44 years old. Colonoscopy was
ranked number 10 for women > 44 years old.
Discussion
This study investigates opportunities for early HIV test-
ing of women in different types of health-care settings.
Of the 3303 South Carolina women with dates of HIV diag-
nosis from January 1, 1996, to December 31, 2007, 2408 (73%)
had previously visited a health-care facility during a period
when it is assumed that they were already HIV-positive, but
they did not receive a diagnostic HIV test. Approximately half
of these women with missed opportunity visits were late
testers and of these, 79% were diagnosed with AIDS within 1
month of their HIV diagnosis. Only one quarter of the women
(24%) with missed opportunity visits for testing were not of
reproductive age ( > 44 years old) but represented half (54%)
of late-testing women. Routine HIV screening in obstetrical
settings is a proven strategy to identify some HIV-infected
women, but the findings of this analysis suggest that women
not of reproductive age may not benefit from routine HIV
screening in this setting. Similarly, although the majority of
visits were to emergency departments, not all women at risk
for HIV infection may visit this health-care venue and
potentially could be identified elsewhere in the system.
The proportion of late-testing women who were not of
reproductive age suggests that a woman’s age may be a factor
in deciding whether an HIV test is accepted or offered. Older
individuals are more likely to refuse testing13–15 and this
 16,983 missed opportunity visits recorded: 
128 BCN2 visits 
1,973 PATS3 visits 
14,882 HD4 visits 
 10,970 ER visits (74%) 
 194 Imaging visits (1%) 
 1,632 Inpatient visits (11%) 
 979 Outpatient visits (7%) 
2,408 (73%) women had visits to 
healthcare facilities prior to initial 
positive HIV diagnosis (missed 
opportunity visits)
3,303 women with dates of initial HIV diagnosis in SC 
from January 1, 1996 to December 31, 20071 
   1,480 (61%) 
non-late testers5
 1,819 (76%) of 
reproductive age 
(13-44 years old)  
928 (39%) 
late testers6
 589 (24%) not of 
reproductive age 
(>44 years old)  
 734 (79%) of late testers diagnosed with 
AIDS < 1 month from HIV diagnosis
FIG. 1. Women with missed opportunities for early human immunodeficiency virus (HIV) testing in South Carolina.
1Obtained from the South Carolina HIV/AIDS Reporting System (eHARS) surveillance database; eligible individuals were
women who were South Carolina residents and ‡ 13 years of age. 2Best Chance Network (BCN) is a federally funded
program that provides cervical and breast cancer screening for women ages 40–64 years old and below 200% federal poverty
level. 3Patient Automated Tracking System (PATS) is database of medical encounters from health department adult health
clinics, including sexually transmitted disease (STD), family planning, and tuberculosis (TB) clinics. 4Hospital discharge (HD)
records from emergency rooms (ER) and inpatient and outpatient facilities in South Carolina. 5Women diagnosed with HIV
disease stage only or with AIDS more than 1 year after HIV diagnosis during the study time period. 6Women diagnosed with
AIDS within 12 months of HIV diagnosis.
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population presents new challenges for testing, prevention,
and education because they are not often targeted or per-
ceived to be at high risk.7 In this analysis, women not of re-
productive age were more likely to have no identified risk or
no risk factor reported to the SCDHEC eHARS surveillance
database as the route of HIV transmission (Table 1). Thus, the
data presented do not support the practice of targeted testing
of risk groups as a viable HIV-screening strategy to identify
older women who are likely HIV infected because this group
does not generally have traditionally perceived risk factors.
In recognition of the increasing numbers of older HIV-
infected individuals, on December 8, 2009, the Centers for
Medicare and Medicaid Services announced the decision
to reimburse for HIV screening. This screening provision in-
cludes individuals who are at increased risk for infection,
women who are pregnant, and Medicare recipients of any age
Table 1. Multiple Logistic Regression Analysis of Missed Opportunities for Early HIV Diagnosis
in Women
a
Categorized by Disease Stage and Reproductive Age, South Carolina,
January 1996 to December 2007
Disease stagea Reproductive age (years)b
Late tester Non–late tester Late vs. non–late testerc 13–44 > 44 13–44 vs. > 44
Characteristic n (%) n (%) aOR 95% CI n (%) n (%) aOR 95% CI
Race/ethnicityd
White, not Hispanic 97 (10) 225 (15) 1.00 — 249 (14) 73 (12) 1.00 —
Black, not Hispanic 810 (87) 1229 (83) 1.48 1.12–1.95 1534 (84) 505 (86) 0.98 0.73–1.32
Transmission categorye
Heterosexual 555 (60) 987 (67) 1.00 — 1218 (67) 324 (55) 1.00 —
Intravenous drug use 61 (7) 102 (7) 0.86 0.60–1.24 126 (7) 37 (6) 1.03 0.69–1.55
No identified risk 183 (20) 212 (14) 1.17 0.91–1.50 271 (15) 124 (21) 1.48 1.14–1.91
No risk reported 125 (13) 174 (12) 0.90 0.68–1.20 198 (11) 101 (17) 1.71 1.29–2.28
Missed opportunity visits
1 visit 161 (17) 306 (21) 1.00 — 367 (20) 100 (17) 1.00 —
2–5 visits 335 (36) 649 (44) 0.99 0.77–1.28 740 (41) 244 (41) 1.27 0.96–1.67
6–10 visits 191 (21) 309 (21) 1.20 0.90–1.61 375 (21) 125 (21) 1.21 0.88–1.66
> 10 visits 241 (26) 216 (14) 2.17 1.62–2.91 337 (19) 120 (20) 1.09 0.79–1.51
Source of report
County health department 215 (23) 562 (38) 1.00 — 642 (35) 135 (23) 1.00 —
Hospital 441 (48) 339 (23) 2.62 2.08–3.29 529 (29) 251 (43) 1.68 1.30–2.17
Private/group practice 207 (22) 370 (25) 1.27 0.99–1.63 212 (12) 62 (11) 1.39 1.06–1.83
Otherf 65 (7) 209 (14) 0.68 0.48–0.95 436 (24) 141 (24) 1.32 0.93–1.88
Age (years)
< 20 16 (2) 126 (9) 1.00 — 142 (8) NAg NA NA
20–24 57 (6) 244 (16) 1.61 0.88–2.96 301 (17) NA NA NA
25–29 90 (10) 231 (16) 2.65 1.47–4.79 321 (18) NA NA NA
30–39 295 (32) 445 (30) 4.65 2.68–8.09 740 (41) NA NA NA
40–44 145 (16) 166 (11) 6.26 3.50–11.2 315 (17) NA NA NA
> 44 321 (35) 268 (18) 7.85 4.49–13.7 NA 589 (100) NA NA
HIV disease stage
Non–late tester NA NA NA NA 1212 (67) 268 (46) 1.00 —
Late tester NA NA NA NA 607 (33) 321 (54) 2.21 1.80–2.70
Payer of servicesh
Commercial 1285 (17) 1123 (15) 1.00 — 1494 (14) 914 (21) 1.00 —
Medicaid 2652 (35) 2956 (40) 0.78 0.70–0.87 4342 (41) 2166 (29) 0.49 0.44–0.55
Medicare 464 (6) 452 (6) 0.54 0.46–0.64 400 (4) 516 (12) 2.15 1.82–2.55
Self-pay 2572 (34) 2354 (32) 1.03 0.92–1.15 3612 (34) 1314 (30) 0.57 0.51–0.63
Otheri 522 (7) 502 (7) 0.89 0.76–1.05 629 (6) 395 (9) 1.04 0.88–1.22
aWomen diagnosed with HIV-only disease stage, or diagnosed with AIDS more than 1 year after HIV diagnosis during the study period;
non–late tester, n = 1480. Women diagnosed with disease stage of AIDS within 12 months of HIV diagnosis; late tester, n = 928.
bWomen of reproductive age defined as age 13-44 years old; n = 1819. Women not of reproductive age defined as age > 44 years old; n = 589.
caOR, adjusted odds ratio; CI, 95% confidence interval.
dWomen of other races (Hispanic, Asian, etc.) were not included in the analysis.
eWomen with other transmission categories (blood transfusion, prenatal, etc.) were not included in the analysis.
fOther source of report category includes South Carolina residents who were reported from other states, from blood banks/businesses,
federal facilities, laboratories, and from unknown sources.
gNA, not applicable.
hPayer of services—derived from the Hospital Discharge dataset at last visit for individuals who had an inpatient, emergency department
or outpatient/ambulatory medical encounter before the date of the first positive HIV test.
iIncludes workers compensation, indigent, charitable organizations, and no report.
Obtained from the South Carolina HIV/AIDS Reporting System (eHARS) surveillance database; eligible individuals were women who
were South Carolina residents and ‡ 13 years of age.
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who voluntarily request the service. This new policy is sig-
nificant; it will facilitate the early detection of HIV infection
for older individuals by removing the barrier to HIV testing
caused by the cost for screening. In this population of HIV-
infected women in South Carolina, Medicaid was 35% of the
payer source for late testers and 29% of the payer source
for women not of reproductive age, and so women not yet
diagnosed may benefit greatly from this revised policy if
routine testing is widely implemented. The proposed Med-
icaid expansion as part of health-care reform offers an op-
portunity to identify these women and ultimately reduce
the cost associated with delayed diagnosis.16–18
There were 16,983 overall missed opportunity visits for early
HIV diagnosis, of which 51% of visits occurred among late
testers and 27% of visits were for women not of reproductive
age. The majority of visits were to hospital emergency de-
partments (74%), which underscores the observation that this
venue remains important in diagnosing women who are un-
aware of their HIV status.1 However, the findings of this
analysis, which includes data reported from health-care facili-
ties, such as radiologic imaging centers and those dedicated to
gynecological procedures, such as Papanicolau screening,
demonstrates that the acceptability and feasibility of routine
HIV screening in nontraditional venues should be investigated.
Women who are not having children and those not of repro-
ductive age may receive United States Preventive Services Task
Force19,20 recommended routine health screenings throughout
their life, and rapid HIV test technology makes testing more
realistic in settings outside of emergency departments. In South
Carolina, expanded routine opt-out HIV screening in nontra-
ditional health-care settings (e.g., radiologic imaging centers)
may further reduce the number of older women who are un-
aware of their HIV-infected status.
We considered all of the health departments PATS data-
base visits, after excluding HIV-related visits, as missed
opportunities for HIV testing. Ideally, all women visiting
these STD, TB, and family planning clinics, regardless of
eventual diagnosis, should be offered an HIV test. In this
study, only 11% of the missed opportunity health-care visits
for late testers and 4% of the visits for women not of re-
productive age were likely to prompt HIV testing in a
nonroutine testing environment. For diagnoses likely to
prompt an HIV test by the provider, STD-related diagnoses
were the most common. AIDS-defining illness/symptom
diagnoses were much more common for late testers than
non–late-testing women. These diagnoses should have
prompted HIV tests. Liddicoat et al.21 found 50% of missed
opportunity visits to a hospital documented an HIV trigger
(i.e., men who have sex with men [MSM]), but HIV testing
was recommended in only 27% of visits with triggers.
Women not of reproductive age accounted for *50% of
AIDS-defining illness/symptom diagnoses (Table 2) while
only accounting for 24% of the South Carolina study pop-
ulation. Again, it appears that these older women are not
being offered testing even though they have physical
symptoms; other studies have shown that older individuals
infected with HIV are not tested because of misdiagnosed
opportunistic infections.9,22
The top procedures were not different for women of dif-
ferent disease stage and age (Table 3); however, women
not of reproductive age are receiving more mammograms
(ranked fourth) than women of reproductive age. Similarly,
Table 2. Number and Percentage of Health-Care Visits and Categories of Diagnosis
by Disease Stage and Reproductive Age of Women Who Had Visited a Heath-Care Facility
Before Date of HIV diagnosis, South Carolina, 1996–2007






non–late tester 13-44 > 44
13-44
vs. > 44
Type of visits before HIV diagnosis n (%) n (%) OR 95% CI n (%) n (%) OR 95% CI
Visits with diagnoses likely to prompt an HIV test
Sexually transmitted diseases
and related diagnoses
1,346 491 (36) 855 (64) 0.58 0.51–0.65 1,216 (90) 160 (10) 2.96 2.50–3.50
AIDS-defining illness/symptomc 482 330 (68) 152 (32) 2.18 1.79–2.64 268 (56) 214 (44) 0.49 0.40–0.59
Abnormal pap/cervical cancer 138 68 (49) 70 (51) 0.97 0.69–1.36 88 (64) 50 (36) 0.69 0.48–0.97
Pregnancy and childbirthd 90 34 (38) 56 (62) 0.61 0.40–0.93 89 (99) 1 (1) — —
Drug/alcohol dependence 280 136 (49) 144 (51) 0.95 0.75–1.20 175 (63) 105 (37) 0.65 0.51–0.83
Visits with diagnoses not likely
to prompt a HIV teste
13,813 6898 (50) 6915 (50) 1.00 Ref. 9945 (72) 3868 (28) 1.00 Ref.
Total visits 16,983 8734 (51) 8249 (49) 12,374 (73) 4609 (27)
aLate testers defined as women diagnosed with disease stage of AIDS within 12 months of HIV diagnosis; n = 928. Women diagnosed with
HIV-only disease stage or diagnosed with AIDS more than 1 year after HIV diagnosis during the study period; non–late tester, n = 1480.
bWomen of reproductive age defined as age 13–44 years old; n = 1819. Women not of reproductive age defined as age > 44 years old;
n = 589.
cAIDS-defining illness/symptom including pulmonary tuberculosis, thrush, recurrent pneumonia, toxoplasmosis, lymphadenopathy, and
unexplained weight loss.
dNot included in the calculation of odds ratios for reproductive age category due to smaller numbers.
eIncluding diabetes, hypertension, and stroke.
Bolded numbers represent values that were statistically significant.
Obtained from the South Carolina HIV/AIDS Reporting System (eHARS) surveillance database; eligible individuals were women who
were South Carolina residents and ‡ 13 years of age.
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late testing women received more Papanicolau screening
(ranked fourth) than non–late testers. Although procedures
(e.g., mammograms) conducted in nontraditional settings
may have initially been ordered by the woman’s primary
care provider, the key objective of CDC Program Colla-
boration and Service Integration23 is to encourage service
providers to offer various interrelated services to persons
wherever they access health service and thereby promote
continuity of care. The advent of rapid HIV testing technology
with test results in 20 minutes makes routine screening in
these environments (mammography, Papanicolau screening)
practical. Strong consideration should be given to study the
acceptability and feasibility of routine screening in these non-
traditional settings especially in locations with high prevalence
of HIV infection. Both providers and patients will need edu-
cation to improve their understanding and acceptance of HIV
testing in these nontraditional environments.
The findings in this report are subject to at least six limita-
tions. First, although eHARS and ORS data are considered
comprehensive, certain HIV/AIDS diagnoses and health-care
visits may not have been reported. Second, women thought not
to have missed opportunity visits may have in fact had medical
encounters that were reported to databases not accessible for
linkage in the current study. Third, although several variables
Table 3. Procedures Performed at Health-Care Visits by Disease Stage and Reproductive
Age of Women Who Had Visited a Heath-Care Facility Before Date
of HIV Diagnosis Ranked by Frequency, South Carolina, 1997–2007
Late testersa Non–late testersb
Rank Top 10 proceduresc
Frequency
of visits Top 10 procedures
Frequency
of visits
1 Brief interview/evaluation (HD) 361 Brief interview/evaluation (HD) 720
2 Injection/infusion of prophylaxis (HD) 158 Injection/infusion of prophylaxis (HD) 210
3 Other x-ray of thorax (HD) 86 Microscopic exam of specimen from
bladder, urine (NOS) (HD)
175
4 Pap smear (HD + BCN) 86 Other x-ray of thorax (HD) 144
5 EGD with closed biopsy (HD) 82 Other manually assisted delivery (HD) 86
6 Microscopic exam of specimen from
bladder, urine (NOS) (HD)
79 Electrocardiogram (HD) 82
7 Transfusion of packed cells (HD) 64 Microscopic exam of blood, toxicology (HD) 80
8 Venous catheterization, not elsewhere
classified (HD)
62 Other puncture of vein (HD) 74
9 Other puncture of vein (HD) 60 Closure of skin and other subcutaneous
tissue (HD)
63
10 Closure of skin and other subcutaneous
tissue (HD)
57 Gynecological examination (HD) 62
Of reproductive aged Not of reproductive agee
Rank Top 10 procedures
Frequency
of visits Top 10 procedures
Frequency
of visits
1 Brief interview/evaluation (HD) 707 Brief interview/evaluation (HD) 374
2 Injection/infusion of prophylaxis (HD) 242 Injection/infusion of prophylaxis (HD) 126
3 Microscopic exam of specimen from
bladder, urine (NOS) (HD)
172 Other x-ray of thorax (HD) 108
4 Other manually assisted delivery (HD) 134 Mammogram (HD + BCN) 94
5 Other x-ray of thorax (HD) 122 EGD with closed biopsy (HD) 80
6 Gynecological exam (HD) 105 Other puncture of vein (HD) 78
7 Closure of skin and other subcutaneous
tissue (HD)
97 Pap smear (HD + BCN) 77
8 Other incision with drainage of skin
and other subcutaneous tissue (HD)
88 Electrocardiogram (HD) 66
9 Other fetal monitoring (HD) 78 Venous catheterization, not elsewhere
classified (HD)
61
10 Insertion of indwelling urinary catheter (HD) 69 Colonoscopy (HD) 43
aLate testers defined as women diagnosed with disease stage of AIDS within 12 months of HIV diagnosis; n = 928
bNon–late testers defined as women diagnosed with HIV disease stage only or with AIDS more than 1 year after HIV diagnosis during the
study time period; n = 1480.
cHD, Hospital Discharge statewide database maintained by the South Carolina Office of Research and Statistics. BCN, Best Chance
Network; federally subsidized program that offers assistance to low-income women to obtain breast and cervical cancer screening; EGD,
esophagogastroduodenoscopy; NOS, not otherwise specified.
dWomen of reproductive age defined as age 13–44 years old; n = 1819.
eWomen not of reproductive age defined as age > 44 years old; n = 589.
Obtained from the South Carolina HIV/AIDS Reporting System (eHARS) surveillance database; eligible individuals were women who
were South Carolina residents and ‡ 13 years of age.
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were available for linking records between the two datasets,
matching might not have been successful in all cases. However,
these three limitations would likely only result in an underes-
timation of the number of missed opportunities for testing.
Fourth, HIV testing might have been recommended but re-
jected by certain patients during earlier visits. Fifth, referral for
HIV testing might have occurred during some of the health-
care encounters before HIV was diagnosed, making these visits
not truly missed opportunities. The incidence of the latter two
issues cannot be addressed with the current dataset, but given
the multitude of visits that were documented for many patients
these occurrences are unlikely to have had a substantial impact.
Finally, certain non–late and late testers might not have been
HIV infected at the time of the previous health-care encounters,
some of which occurred several years before AIDS was diag-
nosed; therefore, those visits might not have represented true
missed opportunities for HIV diagnosis. However, given the
long average latent period of approximately 10 years after HIV
infection before the onset of AIDS and our restriction of visits to
3 years before diagnosis for non–late testers,24 the majority of
individuals were most likely HIV-infected at the time of the
included medical encounters.
In summary, our previous publication identified several
missed opportunities in the general population for early HIV
testing in emergency departments. However, the present
analysis of only women, strongly suggests that the feasibility
and acceptability of implementing a routine HIV testing
program in nontraditional health-care settings should be in-
vestigated. Nontraditional settings located in high prevalence
areas, such as radiologic imaging centers and at the time of
Papanicolau screening, may yet identify HIV-infected women
who are not of reproductive age or are not having chil-
dren. Other settings initially not thought of as ideal venues
for routine HIV screening (e.g., jails, dental clinics, during
labor and delivery),25–28 have all been shown to be suitable
after investigative studies were conducted. This wider im-
plementation of the CDC recommendations is likely to in-
crease the yield of HIV-infected women who can be linked to
care and provided with access to life-saving antiretroviral
therapy. The realization of the full goals of routine screening
will necessitate a revised approach to places where health-
care providers think patients can and should be HIV tested.
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